Table 1 Association between RAE1 expression and clinical features in HCC patients
Characteristic | Low expression of RAE1 | High expression of RAE1 | P |
|---|---|---|---|
Age | 0.435 | ||
< = 60 | 93 (24.9%) | 84 (22.5%) | |
> 60 | 94 (25.2%) | 102 (27.3%) | |
Gender | 0.269 | ||
Female | 55 (14.7%) | 66 (17.6%) | |
Male | 132 (35.3%) | 121 (32.4%) | |
T stage | < 0.001 | ||
T1 | 110 (29.6%) | 73 (19.7%) | |
T2 | 43 (11.6%) | 52 (14%) | |
T3 | 28 (7.5%) | 52 (14%) | |
T4 | 3 (0.8%) | 10 (2.7%) | |
N stage | 0.623 | ||
N0 | 124 (48.1%) | 130 (50.4%) | |
N1 | 1 (0.4%) | 3 (1.2%) | |
Pathologic stage | < 0.001 | ||
Stage I | 103 (29.4%) | 70 (20%) | |
Stage II | 41 (11.7%) | 46 (13.1%) | |
Stage III | 29 (8.3%) | 56 (16%) | |
Stage IV | 3 (0.9%) | 2 (0.6%) | |
Tumor status | 0.012 | ||
Tumor free | 113 (31.8%) | 89 (25.1%) | |
With tumor | 64 (18%) | 89 (25.1%) | |
Histologic grade | < 0.001 | ||
G1 | 35 (9.5%) | 20 (5.4%) | |
G2 | 101 (27.4%) | 77 (20.9%) | |
G3 | 45 (12.2%) | 79 (21.4%) | |
G4 | 4 (1.1%) | 8 (2.2%) | |
AFP(ng/ml) | < 0.001 | ||
< = 400 | 125 (44.6%) | 90 (32.1%) | |
> 400 | 21 (7.5%) | 44 (15.7%) | |
Vascular invasion | 0.165 | ||
No | 113 (35.5%) | 95 (29.9%) | |
Yes | 50 (15.7%) | 60 (18.9%) |